Table 2.
Specific preoperative CCD use reported in colorectal ERAS programs
| Colorectal ERAS programs using a pre-op CCD (n = 68) | Given to patients without diabetes | Given to patients with diabetes not receiving insulin | Given to patients with diabetes receiving insulin |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Clear-Fast® | 18 (29.5) | 16 (31.4) | 12 (31.6) |
| Ensure Pre-Surgery® | 17 (27.9) | 16 (31.4) | 11 (29) |
| Gatorade® | 16 (26.2) | 11 (21.6) | 10 (26.3) |
| Apple juice | 6 (9.8) | 5 (9.8) | 2 (5.3) |
| Other | 4 (6.6)1 | 3 (5.9)2 | 3 (7.9)3 |
1Patients without diabetes—other (4) includes 1 Gatorade® zero, 2 Glycemic Endothelial Drink™ (G.E.D.), and 1 Ensure® clear
2Patients with diabetes not receiving insulin—other (3) includes 1 Gatorade® zero and 2 G.E.D.™
3Patients with diabetes receiving insulin—other (3) includes 1 Gatorade® zero, 1 Gatorade® prime, and 1 G.E.D.™